Table 4. Results of univariable Cox regression model analysis on RFS and OS.
| Univariable Cox regression | HR (95% CI)* | P value |
|---|---|---|
| RFS* | ||
| ASA score* | 0.619 (0.463–0.826) | 0.001 |
| Hypertension | 0.704 (0.534–0.927) | 0.013 |
| Tumor number | 0.504 (0.389–0.652) | 0.000 |
| Cirrhosis | 0.680 (0.486–0.950) | 0.024 |
| Adjuvant chemoradiotherapy | 0.563 (0.430–0.736) | 0.000 |
| AFP* | 0.716 (0.519–0.989) | 0.043 |
| Tumor size | 0.532 (0.414–0.682) | 0.000 |
| Anesthesia methods | 0.640 (0.498–0.822) | 0.000 |
| Ablation methods | 1.241 (0.967–1.593) | 0.089 |
| OS* | ||
| Age | 0.617 (0.396–0.959) | 0.032 |
| ALB* | 0.465 (0.282–0.766) | 0.003 |
| Child-Pugh stage | 0.449 (0.237–0.850) | 0.014 |
| Tumor size | 0.445 (0.285–0.693) | 0.000 |
| Anesthesia methods | 0.632 (0.402–0.993) | 0.046 |
| Ablation methods | 0.723 (0.459–1.139) | 0.160 |
*RFS, recurrence-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; ASA, American Society of Anesthesiologists; AFP, alpha-fetoprotein; ALB, serum albumin.